SCREEN 1 MDPV
Product Code: SC-2061-25
The Screen 1 MDPV Rapid Immersion Test (Urine) is a rapid immunochromatographic test for the qualitative detection of 3,4 methylenedioxypyrovalerone in human urine at a concentration of 1000 ng/mL. 3,4-Methylenedioxypyrovalerone (MDPV) is a psychoactive recreational drug with stimulating properties that acts as a norepinephrine-dopamine reuptake inhibitor (NDRI). MDPV is the 3,4-methylenedioxy substitute analogue of the pyrovalerone compound,used for the treatment of chronic fatigue and as an anorectic, but causes problems of abuse and addiction. However, despite the similar structure, the effects of MDPV have little in common with other derivatives of methylenedioxyphenylalkylamine such as 3,4 methylenedioxy-N-methylamphetamine (MDMA), instead it produces mainly stimulating effects with only mild entactogenic qualities. MDPV undergoes phase 1 metabolism (liver) CYP450 2D6, 2C19, 1A2, and COMT into methylcatechol and pyrrolidine which, in turn, are glucuronated (uridine 5′-diphospho-glucuronosyl-transferase) allowing elimination through kidneys, with only a small fraction of the metabolites excreted in the faeces. It is not possible to find free pyrrolidine in the urine. The MDPV (Urine) rapid immersion test is a rapid urine test that can be performed without the use of instruments. The test uses a monoclonal antibody to selectively detect high levels of 3,4-methylenedioxypyrovalerone in urine. The rapid immersion test MDPV (Urine) gives a positive result when the 3,4-methylenedioxypyrovalerone in the urine exceeds 1000 ng/mL. (The 120ml urine container is supplied separately, you can buy it on the “Accessories” page).